Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), believes that broadening communication and education is COA’s main goal in 2018.
Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), believes that broadening communication and education is COA’s main goal in 2018.
Transcript
What do you see COA’s role being in the coming year in regard to OCM implementation?
Broaden the communication, broaden the education. Someone gave me a book recently and it’s titled The Speed of Trust and I think it’s very practical, very interesting. It talks about how we change in our society, we’re just not as trustful as we need to be.
I think we need to build the trust component in everything we do. Meaning someone called us one time an honest broker. Give it to COA, an honest broker. That’s a very high compliment, but it also comes with a great deal of responsibility. We need to continue that process. Speak openly, speak honestly, do a little education, and bring people home. I've been with COA for 7 years, with a major cancer care team for 13 years, and doing cancer care for 20 years, and though we’ve been saying the same thing for 5 or 6 years, recently someone who I’ve known for a long time says, "In the sales community you have to say it 6 times before it resonates." So I’m thinking, "okay we need to say it 6 times real fast," but we have to take our time, rearrange our words, say them differently so that it makes sense and it sits with people. And they have that V8 moment like, "wow I need to," and then they’ll implement it. There will be a lot of fault starts but you have to encourage them so they can continue to move forward.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More